CVS Health Partners With Wegovy Maker Novo Nordisk, Hikes 2025 Guidance
1. CVS Q1 sales reached $94.59 billion, exceeding estimates. 2. Adjusted EPS rose significantly to $2.25, above expectations. 3. Health Care Benefits segment drove major revenue growth, especially in Medicare. 4. Operating income increased by 54.9%, reflecting strong performance across segments. 5. CVS raised 2025 EPS guidance, indicating positive future outlook.